The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
Breast Cancer Res
; 13(1): R16, 2011 Feb 03.
Article
em En
| MEDLINE
| ID: mdl-21291529
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tamoxifeno
/
Neoplasias da Mama
/
Epirubicina
/
Prolil Hidroxilases
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
Idioma:
En
Revista:
Breast Cancer Res
Ano de publicação:
2011
Tipo de documento:
Article